Good morning, everyone, and welcome to another working week. We hope the weekend respite was invigorating and refreshing, because that oh-so familiar routine of online meetings, calls, and deadlines has predictably returned, But what can you do? The world, such as it is, continues to spin. So to cope, we are brewing cups of stimulation — our choice today is cinnamon hazelnut. Meanwhile, we have assembled another menu of tidbits for you to peruse, and we hope you have a smashing day and conquer the world. And of course, do keep in touch. …
The U.S. Food and Drug Administration approved a new, rapid-acting medicine made by Sage Therapeutics to treat postpartum depression, the first oral treatment for the condition, STAT writes. But the agency rejected an indication for major depression, a much larger potential market. Biogen will co-market the drug, which will be sold under the…
Click here to view original post
